Management of Persistent Right-Sided Weakness Post-Stroke

Understanding the Clinical Context

The American Heart Association recommends that patients with a history of stroke, such as the one described, face a 17-35% estimated 10-year risk of recurrent vascular events, depending on the number and control of modifiable risk factors present, including hypertension, diabetes, hyperlipidemia, and smoking 1, 2
Patients with cerebrovascular disease have an 18% risk of recurrent stroke within 5 years, with 5% experiencing myocardial infarction in the first year and 3% per year thereafter, according to the American Stroke Association 4

The American College of Cardiology recommends aspirin 75-150 mg daily for patients with cerebrovascular disease, if not already on antiplatelet therapy, which reduces vascular events by 36 per 1000 patients treated over 27 months 3, 5
The European Society of Cardiology suggests considering adding clopidogrel 75 mg daily for dual antiplatelet therapy for 9-12 months if this represents a recent evaluation of a prior stroke 5
The American Heart Association recommends targeting blood pressure management to <140/90 mmHg (or <130/80 mmHg if diabetic), with 43-68% of patients with vascular disease failing to meet blood pressure targets 1, 2
The American College of Cardiology recommends initiating or intensifying antihypertensive therapy immediately if above target, with ACE inhibitors or ARBs preferred, especially with diabetes or heart failure 3, 6
The European Atherosclerosis Society recommends targeting LDL cholesterol <70 mg/dL (<1.8 mmol/L) for secondary prevention, with 85-95% of patients with vascular disease failing to meet lipid targets 1, 7
The American Diabetes Association recommends targeting HbA1c <7% with individualized goals based on comorbidities, with only 23-30% of diabetic patients with vascular disease having adequate glycemic control 1

The American Heart Association emphasizes that smoking cessation is mandatory, as this is a major modifiable risk factor, with 23-61% of patients with vascular disease continuing to smoke despite their diagnosis 3, 5
The American College of Cardiology recommends referring to smoking cessation programs and considering nicotine replacement therapy 5

The American Heart Association recommends structured exercise therapy to improve functional status and reduce cardiovascular risk, with after-stroke exercise integrated with comprehensive risk factor management able to lower the risk of recurrent stroke by up to 80% 4, 8
The American College of Cardiology suggests that physical therapy evaluation for the persistent right-sided weakness may optimize functional recovery, even years after the initial event 3

The European Society of Cardiology recommends scheduling regular follow-up every 3-6 months to assess blood pressure control, lipid panel results, medication adherence, functional status, and quality of life 5, 6, 8
The American College of Cardiology suggests that depression screening should be performed, as it is prevalent in patients with stroke and associated with adverse outcomes 8
The American Heart Association recommends coordinating care among primary care, neurology, and cardiology to ensure comprehensive risk factor management 8